CTIS2024-511468-94-00招募中1 期
A study to learn how safe KER-0193 is, the activity of KER-0193 in the body over a period of time, and the effect of KER-0193 to the body in adult healthy people taking single and multiple doses by the mouth that are increased a little at a time
Kaerus Bioscience Limited0 个研究点目标入组 80 人开始时间: 2024年4月29日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
1 期
Safety, Tolerability, and Immunoregulatory Activity of Mogamulizumab (KW-0761) in Subjects With Advanced and/or Metastatic Solid TumorsAdvanced Solid TumorsMetastatic Solid TumorsNCT02281409Memorial Sloan Kettering Cancer Center17
Unknown
2 期
Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot UlcersFoot UlcerDiabetesNCT00330265KeraCure300
进行中（未招募）
1 期
Study to evaluate the safety, tolerability and efficacy of AZD4831 in thetreatment of patients with pulmonary hypertensioEUCTR2020-002788-80-DEniversity of Cologne15
招募中
1 期
The development of a novel self-activating device to improve the nasal deformity for cleft lip/palate patientscleft lip and palateJPRN-jRCTs032210533Kobayashi Shinji10
撤回
1 期
A Clinical Trial of CK0801 (a New Drug) In Patients With Treatment-Resistant Guillain-Barré Syndrome (GBS)Guillain-Barré SyndromeNCT03773328Cellenkos, Inc.